Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F10%3A00002563" target="_blank" >RIV/00216208:11120/10:00002563 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery

Popis výsledku v původním jazyce

Percutaneous coronary interventions have become the most commonly performed coronary revascularization procedures. At the same time, the probability has been increased that patients with intracoronary stents will have to undergo surgery. We can project that, in the Czech Republic, one thousand patients undergo non-cardiac surgery within six months of stent implantation annually. Two serious consequences emerge from this situation: (i) stent thrombosis in relation to discontinuation of antiplatelet therapy, and (ii) major bleeding in relation to continuation of antiplatelet therapy. The best solution to overcome the risks resulting from surgery performed in patients after stent implantation is to postpone the procedure until after re-endothelializationof the vessel surface has been completed. Because only approximately 5-10% of surgeries are performed as an urgent procedure, this could be a signifi cant way to increase the safety of non-cardiac surgical procedures following stent impla

Název v anglickém jazyce

Antithrombotic therapy in patients at risk for coronary stent thrombosis undergoing non-cardiac surgery

Popis výsledku anglicky

Percutaneous coronary interventions have become the most commonly performed coronary revascularization procedures. At the same time, the probability has been increased that patients with intracoronary stents will have to undergo surgery. We can project that, in the Czech Republic, one thousand patients undergo non-cardiac surgery within six months of stent implantation annually. Two serious consequences emerge from this situation: (i) stent thrombosis in relation to discontinuation of antiplatelet therapy, and (ii) major bleeding in relation to continuation of antiplatelet therapy. The best solution to overcome the risks resulting from surgery performed in patients after stent implantation is to postpone the procedure until after re-endothelializationof the vessel surface has been completed. Because only approximately 5-10% of surgeries are performed as an urgent procedure, this could be a signifi cant way to increase the safety of non-cardiac surgical procedures following stent impla

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2010

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

52

Číslo periodika v rámci svazku

Suppl. 1

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

6

Strana od-do

—

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—